348 related articles for article (PubMed ID: 33692466)
1. Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts.
Berdiel-Acer M; Maia A; Hristova Z; Borgoni S; Vetter M; Burmester S; Becki C; Michels B; Abnaof K; Binenbaum I; Bethmann D; Chatziioannou A; Hasmann M; Thomssen C; Espinet E; Wiemann S
Oncogene; 2021 Apr; 40(15):2651-2666. PubMed ID: 33692466
[TBL] [Abstract][Full Text] [Related]
2. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast Cancer.
Guardia C; Bianchini G; Arpí-LLucià O; Menendez S; Casadevall D; Galbardi B; Dugo M; Servitja S; Montero JC; Soria-Jiménez L; Sabbaghi M; Peña R; Madoz-Gúrpide J; Lloveras B; Lluch A; Eroles P; Arribas J; Pandiella A; Gianni L; Rojo F; Rovira A; Albanell J
Clin Cancer Res; 2021 Sep; 27(18):5096-5108. PubMed ID: 34385295
[TBL] [Abstract][Full Text] [Related]
4. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.
Zhang Z; Karthaus WR; Lee YS; Gao VR; Wu C; Russo JW; Liu M; Mota JM; Abida W; Linton E; Lee E; Barnes SD; Chen HA; Mao N; Wongvipat J; Choi D; Chen X; Zhao H; Manova-Todorova K; de Stanchina E; Taplin ME; Balk SP; Rathkopf DE; Gopalan A; Carver BS; Mu P; Jiang X; Watson PA; Sawyers CL
Cancer Cell; 2020 Aug; 38(2):279-296.e9. PubMed ID: 32679108
[TBL] [Abstract][Full Text] [Related]
5. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic
Odintsov I; Lui AJW; Sisso WJ; Gladstone E; Liu Z; Delasos L; Kurth RI; Sisso EM; Vojnic M; Khodos I; Mattar MS; de Stanchina E; Leland SM; Ladanyi M; Somwar R
Clin Cancer Res; 2021 Jun; 27(11):3154-3166. PubMed ID: 33824166
[TBL] [Abstract][Full Text] [Related]
6. NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
Yang L; Li Y; Shen E; Cao F; Li L; Li X; Wang X; Kariminia S; Chang B; Li H; Li Q
Int J Oncol; 2017 Nov; 51(5):1553-1562. PubMed ID: 29048656
[TBL] [Abstract][Full Text] [Related]
7. FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts.
Wan X; Guan S; Hou Y; Qin Y; Zeng H; Yang L; Qiao Y; Liu S; Li Q; Jin T; Qiu Y; Liu M
Theranostics; 2021; 11(10):4975-4991. PubMed ID: 33754039
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanoma.
Capparelli C; Rosenbaum S; Berger AC; Aplin AE
J Biol Chem; 2015 Oct; 290(40):24267-77. PubMed ID: 26269601
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.
Jeong H; Kim J; Lee Y; Seo JH; Hong SR; Kim A
Oncol Rep; 2014 Sep; 32(3):1218-24. PubMed ID: 25018110
[TBL] [Abstract][Full Text] [Related]
10. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion.
Zhang Z; Tao D; Zhang P; Liu X; Zhang Y; Cheng J; Yuan H; Liu L; Jiang H
J Exp Clin Cancer Res; 2016 Nov; 35(1):181. PubMed ID: 27884164
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
13. Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers.
Odintsov I; Mattar MS; Lui AJW; Offin M; Kurzatkowski C; Delasos L; Khodos I; Asher M; Daly RM; Rekhtman N; de Stanchina E; Ganji G; Ladanyi M; Somwar R
J Thorac Oncol; 2021 Jul; 16(7):1149-1165. PubMed ID: 33839363
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.
Le Clorennec C; Bazin H; Dubreuil O; Larbouret C; Ogier C; Lazrek Y; Garambois V; Poul MA; Mondon P; Barret JM; Mathis G; Prost JF; Pèlegrin A; Chardès T
Mol Cancer Ther; 2017 Jul; 16(7):1312-1323. PubMed ID: 28507002
[TBL] [Abstract][Full Text] [Related]
15. Adipose Stromal Cell-Derived Cancer-Associated Fibroblasts Suppress FGFR Inhibitor Efficacy.
Kolonin MG; Anastassiou D
Cancer Res; 2024 Mar; 84(5):648-649. PubMed ID: 38437636
[TBL] [Abstract][Full Text] [Related]
16. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
17. An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin.
Garner AP; Bialucha CU; Sprague ER; Garrett JT; Sheng Q; Li S; Sineshchekova O; Saxena P; Sutton CR; Chen D; Chen Y; Wang H; Liang J; Das R; Mosher R; Gu J; Huang A; Haubst N; Zehetmeier C; Haberl M; Elis W; Kunz C; Heidt AB; Herlihy K; Murtie J; Schuller A; Arteaga CL; Sellers WR; Ettenberg SA
Cancer Res; 2013 Oct; 73(19):6024-35. PubMed ID: 23928993
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells.
Han ME; Kim HJ; Shin DH; Hwang SH; Kang CD; Oh SO
J Gastroenterol; 2015 Jun; 50(6):645-56. PubMed ID: 25381017
[TBL] [Abstract][Full Text] [Related]
19. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
[TBL] [Abstract][Full Text] [Related]
20. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
